Our Scientific and Administrative Management Team:

John R. Cashman. Ph.D., President and Founder, has more than 23 years experience in biomedical research as a researcher, consultant, entrepreneur or administrator. In 1997, he founded the Human BioMolecular Research Institute, a non-profit research institute dedicated to performing fundamental and applied research to address important human diseases of the central nervous system. Previously, he was Senior Scientist at the Seattle Biomedical Research Institute and prior to that, he was Associate Director for the IGEN Research Institute in Seattle, Washington. In 1984, he was appointed Assistant Professor of Chemistry and Pharmaceutical Chemistry at the University of California, San Francisco. He completed a postdoctoral fellow in the Department of Chemistry at Harvard University in Cambridge, Massachusetts with Professor E.J. Corey (1982-1984). In 1990, Professor Corey received the Nobel Prize. Dr. Cashman received his Masters and doctorate degrees in Medicinal Chemistry from the University of Kansas, Lawrence, Kansas (1982). Prior to graduate school, he obtained bachelor degrees in chemistry and biology at the College of Creative Studies, University of California, Santa Barbara (1977). Dr. Cashman was a University of California Presidents Undergraduate Researcher (1974-1976), received a Sigma Xi Undergraduate Research fellowship (1975), was a PEW Scholar Nominee at the University of California, San Francisco (1986), received a March of Dimes Basil O’Connor Research Award (1986), was appointed Technical Advisor, San Francisco Estuary Project (1990) and was elected Fellow of the American Association for the Advancement of Science in 1996. In 1991, Dr. Cashman was appointed to the Editorial Advisory Board, Chemical Research in Toxicology and in 1999 he was appointed to the Editorial Advisory Board of Current Drug Metabolism. Dr. Cashman is the author of over 150 research articles or book chapters and 6 patents in the area of drug discovery and evaluation. He is extensively consulted by biotechnology, pharmaceutical industry and government in various areas of human drug development, drug safety evaluation, medicinal chemistry, pharmacogenetics and biochemical toxicology. Dr. Cashman is on the Board of Directors of three biotechnology companies.

Click Here to View a list of Publications by John R. Cashman, Ph.D

Karl Okolotowicz, Ph.D. - Chemistry

Mary Dwyer, Ph.D. - Biology

Sigeng Chen, Ph.D. - Biology

Emily Smith - Biology

Rebekah Handley, Chief Operating Officer. Since 2006 Mrs. Handley has served as the institute's Chief Operating Officer. Prior to her current position, Mrs. Handley was the Senior Administrative Officer at HBRI. She received her B.A. in Business Administration from Point Loma Nazarene University in 2002.

Institute Affiliate Members

Geraldine Lampkin, M.S., Associate Scientist

Ronald Christopher, Ph.D., Associate Scientist

Nicholas Schork, Ph.D., Associate Scientist

Milan Fiala, M.D., Associate Scientist

James Leushner, Ph.D., Associate Scientist